April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving clinical and technical research to advance innovation for pediatric care delivery across modalities, including magnetic resonance imaging (MRI), ultrasound, molecular imaging (MI) and computed tomography (CT).

April 7, 2025 — DOSIsoft, a provider of patient-specific imaging and dosimetry software solutions, recently announced the latest release of PLANET Onco Dose version 3.2 – multi-radionuclide, personalized, voxel-based dosimetry platform for SIRT and MRT – has received FDA 510(k) clearance in the U.S. and is now approved for market in EU under CE MDR Mark.

End-to-end, versatile, vendor-neutral, the novel PLANET release is specially designed to integrate multi-radionuclide, implement multi-workflow and support multi-therapy.

April 3, 2025 — Siemens Healthineers and Tower Health have formed a 10-year Value Partnership1 focused on equipment enhancement, technology modernization and improving clinical experience for patients. The Value Partnership will bring comprehensive improvements in diagnostic imaging and digital intelligence tools to radiology, oncology and cardiology across the Tower Health system.

Tower Health is a regional integrated healthcare system that offers compassionate, high-quality, leading-edge healthcare and wellness services to communities in Pennsylvania.

March 31, 2025 — MedStar Georgetown University Hospital is the first hospital in the Washington, D.C. region to offer bedside intestinal ultrasound (IUS) to monitor inflammation in IBD patients. To assess chronic inflammatory diseases of the intestines, like Crohn's disease and ulcerative colitis, patients are traditionally monitored with blood tests, stool studies, MRI or CT scans, and colonoscopies. Those kinds of tests can require bowel preparation, sedation, anesthesia, and radiation.

March 31, 2025 — Neuropathic pain affects up to 10 percent of the global population and can be challenging to manage effectively with existing medications.

April 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT, has announced that the FDA has approved an Investigational Device Exemption (IDE) application to initiate a pilot study for the treatment of patients with recurrent glioblastoma (GBM) using the Alpha DaRT technology.

March 28, 2025 — Novartis has announced that the US Food and Drug Administration (FDA) approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treated with an androgen receptor pathway inhibitor (ARPI) therapy and are considered appropriate to delay chemotherapy.

March 24, 2025 — The first X-ray machine to be used on astronauts in space features advanced detector technology developed in Canada. The SpaceXray research project is a collaboration between leading academic institutions, private companies and technology innovators across North America.

March 20, 2025 — GE HealthCare has launched Invenia Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound offering advanced artificial intelligence (AI) and innovative features to drive faster*, reproducible supplemental screening and streamline exam readings on patients with dense breasts.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now